Navigation Links
Cambrex Reports Fourth Quarter And Full Year 2012 Financial Results
Date:2/6/2013

nt signed during the third quarter of 2012 including that the Company will expend significant resources to expand its manufacturing facilities without any assurance that the new agreement will generate any revenue beyond revenue that would be earned under termination provisions within the agreement, that the customer's product candidate will be successful in Phase 3 trials or obtain the necessary regulatory approvals to commercialize the product candidate, that the customer's Phase 3 program will not be terminated early, that anticipated quantities will not be meaningfully reduced, that the planned Phase 3 and pre-launch activities will proceed on the timeline anticipated, if at all, that the Company's expansion will proceed on the anticipated timeline without disruption to existing customers or our new customer and without disruption to the Company's and its customers' ability to meet key product delivery milestones.

For further details and a discussion of these and other risks and uncertainties, investors are encouraged to review the Cambrex Annual Report on Form 10-K for the fiscal year ended December 31, 2011 and when it becomes available, for the fiscal year ended December 31, 2012, including the Forward-Looking Statement sections therein, and other filings with the SEC.  We caution investors and potential investors not to place significant reliance on the forward-looking statements contained in this press release and to give careful consideration to the risks and uncertainties listed above and contained in our SEC filings. The forward-looking statements in this press release speak only as of the date of this document, and we undertake no obligation to update or revise any of these statements.

Use of Non-GAAP Financial MeasuresEBITDA is a non-GAAP financial measure, which the Company defines as operating profit plus depreciation and amortization expense.  Other companies may have a different definition of EBITDA and, therefore, EB
'/>"/>

SOURCE Cambrex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Cambrex Reports First Quarter 2012 Results
2. Cambrex To Present At Jefferies 2012 Global Healthcare Conference
3. Cambrex Announces Significant New Supply Agreement
4. Cambrex to Announce Third Quarter 2012 Financial Results on October 31, 2012
5. Cambrex Reports Third Quarter 2012 Financial Results
6. Cambrex To Announce Fourth Quarter 2012 Financial Results On February 6, 2013
7. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
8. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
9. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
10. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
11. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015  Perrigo Company plc ... its Board of Directors has unanimously rejected the unsolicited ... MYL ), disclosed April 8, 2015, to acquire all ... share. Following a thorough review, advised by its financial ... Proposal substantially undervalues the Company and its future growth ...
(Date:4/21/2015)... , 21. April 2015  CorTechs Labs, ... quantitative Analyse des Hirnvolumens freut sich, eine ... Pharmaunternehmen, bekannt geben zu können. Die Unternehmen ... des Hirnvolumens zusammenarbeiten, der die Identifizierung, Messung ... Patienten mit multipler Sklerose als Ziel hat. ...
(Date:4/21/2015)... WASHINGTON , April 21, 2015 ... the National Minority Quality Forum (NMQF), today ... president of the Pharmaceutical Research and Manufacturers of ... diversity in clinical trials. On behalf of PhRMA, and ... In " campaign to build awareness, start conversations, and ...
Breaking Medicine Technology:Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 2Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 3Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 4Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 5Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 6Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 7Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 8Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 9CorTechs Labs kündigt Partnerschaft für die Bereitstellung umfassender Lösungen zur Quantifizierung des Verlustes von Hirnvolumen bei multipler Sklerose an 2National Minority Quality Forum to Award PhRMA President John Castellani for Leadership in Increasing Clinical Trial Diversity 2National Minority Quality Forum to Award PhRMA President John Castellani for Leadership in Increasing Clinical Trial Diversity 3
... 18 Misonix, Inc. (Nasdaq: MSON ), ... device technology, which worldwide is used for acute health ... Organization ("GPO") Agreement with First Choice Cooperative ("FCC"), headquartered ... Misonix will offer FCC members the opportunity to purchase ...
... Medical, Inc. (OTC Bulletin Board: AEMD ), ... infectious disease and cancer, today announced that it has ... to expand the opportunity for Aethlon to commercialize its ... centers in India.  The therapeutic focus at each center ...
Cached Medicine Technology:Misonix Announces New GPO Agreement With First Choice Cooperative 2Misonix Announces New GPO Agreement With First Choice Cooperative 3Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs 2Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs 3Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs 4Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs 5
(Date:4/21/2015)... 2015 On April 2, 2015, Elle ... Achieve Kylie Jenner Lips With Disastrous Results,” ... themselves while attempting an at-home lip augmentation ... that creating an airlock around one’s mouth for several ... and achieve Kylie Jenner’s now famous pout. (see: goo.gl/dFQW2L) ...
(Date:4/21/2015)... April 21, 2015 “ ZeroWire ” ... Tech Report, which takes a look at the latest ... Scott Steinberg, a special reporter for NewsWatch and a ... how ZeroWire is a security system and lifestyle management ... there were over 2 million burglaries in 2010. It ...
(Date:4/21/2015)... Lewisville, TX (PRWEB) April 21, 2015 ... (NYSE:ADPT) announced today it is opening its first freestanding ... located in Chandler, Arizona and will be licensed under ... of the Dignity Health and Adeptus Health joint venture. ... Chandler Regional and Mercy Gilbert Medical Centers said the ...
(Date:4/21/2015)... 2015 Wireless Analytics, LLC , ... recognized by the Boston Business Journal as the 25th ... announced at a recent event celebrating the 2015 ... fastest-growing private companies in Massachusetts. , Wireless Analytics was ... that recorded the fastest revenue growth from 2011 through ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 ... 2015” provides comparative analysis on the therapeutic ... R&D pipelines by identifying new targets and ... Complete report with TOC is available @ ... also reviews key players involved in the ...
Breaking Medicine News(10 mins):Health News:Celebrity Cosmetic Surgeon Comments on Report of Teen Girls Injuring Themselves Attempting Kylie Jenner-Inspired Twitter Challenge 2Health News:A Leader in Home Security was Featured on NewsWatch Television 2Health News:Dignity Health and Adeptus Health to Open First Freestanding Emergency Room in Chandler, Arizona 2Health News:Dignity Health and Adeptus Health to Open First Freestanding Emergency Room in Chandler, Arizona 3Health News:Wireless Analytics Ranked as 25th Fastest Growing Private Company in Massachusetts 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4
... Kids seem to be ignoring message that methamphetamine is ... anti-methamphetamine campaign that utilizes graphic images actually may not ... Montana Meth Project (MMP), created in 2005, featured images ... once." The perceived success of the program had resulted ...
... RALEIGH, N.C., Dec. 11 PRA International, a ... new office in,Mexico City, Mexico. With years ... market in 2005. The region,s existing base ... and infectious diseases,match favorably to PRA,s therapeutic focus. ...
... Drive China,s Psychiatric Drug Market to Reach Nearly $1 Billion ... , , WALTHAM, Mass., Dec. ... and advisory firms focusing on pharmaceutical and healthcare issues, finds ... remain. According to the new special Emerging Markets report entitled ...
... Cytometer System Twice Yearly to Support Innovative Research and Expand ... -Learn More about the Revolutionary Accuri C6 Flow ... , , ANN ARBOR, Mich., ... developing revolutionary bench-top flow cytometer systems, today announced the first ...
... Puppies , , RHINELANDER, Wis., Dec. ... Joshua Tree, California, has been an avid animal lover, trainer and ... Gene,s first dog was no exception. He would have to give ... began Gene,s life long passion for breeding and training animals. ...
... Access to Renal Function and MetLyte 8 Panels for ... UNION CITY, Calif., Dec. 11 Abaxis, Inc. (Nasdaq: ... point-of-care blood analysis systems, today announced that the U.S. ... under CLIA regulations for two additional analytes, Creatine Kinase ...
Cached Medicine News:Health News:Study Questions Value of Anti-Meth Campaign 2Health News:PRA International Expands Operations in Mexico 2Health News:China's Views on Mental Disorders Improving but Challenges Remain 2Health News:China's Views on Mental Disorders Improving but Challenges Remain 3Health News:Researcher Receives Free C6 Flow Cytometer(R) System as First Winner of Accuri Flow Cytometer(R) Creativity Awards Program 2Health News:Researcher Receives Free C6 Flow Cytometer(R) System as First Winner of Accuri Flow Cytometer(R) Creativity Awards Program 3Health News:Researcher Receives Free C6 Flow Cytometer(R) System as First Winner of Accuri Flow Cytometer(R) Creativity Awards Program 4Health News:20,000,000th Phone Order Placed at Doctors Foster & Smith Pet Supplies 2Health News:Abaxis Point-of-Care Test Panels Gain FDA CLIA-Waived Status 2Health News:Abaxis Point-of-Care Test Panels Gain FDA CLIA-Waived Status 3Health News:Abaxis Point-of-Care Test Panels Gain FDA CLIA-Waived Status 4
Used for the introduction of catheters, balloons and other vascular devices....
Used to introduce balloon, electrode, closed or non-tapered end catheters and other devices for intervention....
Used for contralateral access to the iliac artery for interventional procedures after initial wire guide positioning has been established....
Used to introduce balloon, electrode, closed or non-tapered end and other catheters....
Medicine Products: